CardioDx Receives College of American Pathologists (CAP) Accreditation by longitudeadmin | May 9, 2013 | Uncategorized
Esperion announces results from Phase 1 study and four preclinical studies for ETC-1002 by longitudeadmin | May 4, 2013 | Portfolio News
Esperion Therapeutics Presents Full Results of Phase 2 Clinical Trial Showing Its Novel Oral Therapy ETC-1002 Lowered LDL-C By Up to 43 Percent in Hypercholesterolemic Patients with Type 2 Diabetes by longitudeadmin | May 2, 2013 | Portfolio News
NxStage Announces FDA Clearance for New High Flow Capabilities with NxStage System One by longitudeadmin | Apr 30, 2013 | Portfolio News
Collegium Announces Results of Chronic Pain Patient Survey – Confirms Significant Unmet Medical Need for a Differentiated, Abuse-Deterrent, Extended-Release Opioid by longitudeadmin | Apr 30, 2013 | Portfolio News
